患者特点

低SII/ALB组

高SII/ALB组

(n = 36)

(n = 35)

性别

男

8 (22.2%)

15 (42.9%)

女

28 (77.8%)

20 (57.1%)

年龄(岁)

<65

26 (72.2%)

15 (42.9%)

³65

10 (27.8%)

20 (57.1%)

肿瘤分期

III期

19 (52.8%)

4 (11.4%)

IV期

17 (47.2%)

31 (88.6%)

靶向药物

厄洛替尼

13 (36.1%)

14 (40.0%)

吉非替尼

23 (63.9%)

21 (60.0%)

血清白蛋白ALB (g/L)

<35

4 (11.1%)

22 (62.9%)

³35

32 (88.9%)

13 (37.1%)

中性粒细胞计数(10⁹/L)

<6.3

36 (100.0%)

29 (82.9%)

³6.3

0 (0.0%)

6 (17.1%)

淋巴细胞计数(10⁹/L)

<1.1

19 (52.8%)

10 (28.6%)

³1.1

17 (47.2%)

25 (71.4%)

血小板计数(10⁹/L)

<300

33 (91.7%)

17 (48.6%)

³300

3 (8.3%)

18 (51.4%)